Home > Latest News > HTC activities taken to the extreme

HTC activities taken to the extreme

Over 300 delegates from 33 countries attended the World Extreme Medicine Conference in Edinburgh in November, where the HTC led a session on biomedical innovations.

The Colorectal Therapies HTC facilitated the session, inviting the WoundTec, Brain Injury and Cardiovascular HTCs to take part and present some of their most interesting innovations.

From the Colorectal HTC, Biosensing Theme Lead Professor Paul Millner presented on the development of biosensors for real time point-of-care monitoring of diagnostic and prognostic trauma biomarkers. See here for more details of Professor Millner’s presentation

Clinical Director of WoundTec HTC, Professor Steven Jeffery from Queen Elizabeth Hospital, Birmingham, presented new technologies for the prevention and treatment of wounds, with a particular focus on wound imaging in the field. Professor Jeffrey introduced recent technological advances in the use of 3D imaging technology in medicine and highlighted the benefits this provided in ‘seeing’ bacteria in real time to allow more targeted treatment of contaminated wounds.

Mr Mark Wilson from Imperial Healthcare Trust and London’s Air Ambulance, who leads on Primary Prevention for the Brain Injury HTC, highlighted the areas of unmet need for developing technology-based solution amongst patients of all ages with Traumatic (TBI), Acquired (ABI) or Developed (DBI) Brain Injury. Mark highlighted that while research in the last two decades has focused on in-hospital care, there is a need to address pre-hospital care and in particular pre-hospital imaging of head injured patients.

Also presenting was Dr Pablo Lamata from Kings College London, who is the Cardiovascular HTC’s technical lead for Paediatric Technologies. Dr Lamata presented developments in new medical devices and technology driven solutions that will improve the diagnosis, treatment and well-being of patients with cardiovascular disease. He particularly focused on the importance of the synergy between computational models and clinical data in cardiovascular medicine.

Dr Lorna Dougan, from the University of Leeds, who attended as a HTC representative, said: “The World Extreme Medicine Conference was a unique opportunity to meet with medics who specialise in medicine in challenging, remote and austere environments. This is the first time the event included a focus on nanotechnology and remote diagnosis tools, and it was great that the HTC’s were able to make such a valuable contribution by presenting the very latest developments in biomedical innovations.”